100%
#SNGSynairgen plc
as of 2024-12-20
1M : -56.43%
6M : -64.22%
1Yr : -70.15%
32.50%
Company Profile
Name: Synairgen plc
Code: SNG
Exchange: LSE
Country: UK
ISIN: GB00B0381Z20
Sector: Healthcare
Industry: Biotechnology
Address: Mailpoint 810, Southampton, United Kingdom, SO16 6YD
Fulltime Employees: 36.00

Profile Description:

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Financial News Sentiment

News Sentiment